Insider Trading: IDEXX Laboratories Inc (IDXX.OQ)
IDXX.OQ on NASDAQ Stock Exchange Global Select Market
85.90USD
12:19pm EDT
85.90USD
12:19pm EDT
Price Change (% chg)
$0.25 (+0.29%)
$0.25 (+0.29%)
Prev Close
$86.40
$86.40
Open
$85.65
$85.65
Day's High
$86.02
$86.02
Day's Low
$85.48
$85.48
Volume
22,764
22,764
Avg. Vol
114,051
114,051
52-wk High
$101.18
$101.18
52-wk Low
$81.39
$81.39
NAQUI ALI
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 8 May 2013 | Buy | 14,779 | $56.95 | 17,513 |
| 8 May 2013 | Sell | 12,961 | $87.00 | 17,513 |
| 13 Feb 2013 | Sell | 388 | $91.68 | 15,695 |
| 13 Feb 2013 | Buy | 143 | $0.00 | 15,695 |
| 13 Feb 2013 | Buy | 257 | $0.00 | 15,695 |
| 13 Feb 2013 | Buy | 363 | $0.00 | 15,695 |
| 13 Feb 2013 | Buy | 161 | $0.00 | 15,695 |
| 13 Feb 2013 | Buy | 281 | $0.00 | 15,695 |
| 30 Jan 2013 | Sell | 8,540 | $95.53 | 14,878 |
| 30 Jan 2013 | Buy | 11,498 | $41.94 | 14,878 |
| 13 Nov 2012 | Sell | 3,504 | $90.05 | 11,920 |
| 31 Jul 2012 | Sell | 5,000 | $87.84 | 15,424 |
| 1 May 2012 | Sell | 6,674 | $87.75 | 20,424 |
| 1 May 2012 | Buy | 9,434 | $38.34 | 20,424 |
| 13 Feb 2012 | Buy | 162 | $0.00 | 17,664 |
| 13 Feb 2012 | Sell | 455 | $87.42 | 17,664 |
| 13 Feb 2012 | Buy | 282 | $0.00 | 17,664 |
| 13 Feb 2012 | Buy | 364 | $0.00 | 17,664 |
| 13 Feb 2012 | Buy | 268 | $0.00 | 17,664 |
| 13 Feb 2012 | Buy | 257 | $0.00 | 17,664 |
| 30 Jan 2012 | Sell | 3,056 | $84.64 | 16,786 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 352 |
| Total Shares Held: | 54,485,850 |
| 3 Mo. Net Change: | -347,423 |
| # New Positions: | 34 |
| # Closed Positions: | 33 |
| # Increased Positions: | 154 |
| # Reduced Positions: | 144 |
| # Net Buyers: | 10 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Jonathan Ayers |
57 | 2002 | Chairman of the Board, President, Chief Executive Officer |
Willard Blanche |
39 | 2013 | Acting Chief Financial Officer, Vice President - Finance |
William Brown |
58 | 2012 | Executive Vice President, Chief Scientific Officer |
Jeffrey Fiarman |
44 | 2013 | Executive Vice President, General Counsel |
Jay Mazelsky |
52 | 2012 | Executive Vice President |
Johnny Powers |
51 | 2012 | Executive Vice President |
Michael Williams |
45 | 2012 | Executive Vice President |
Daniel Meyaard |
55 | 2009 | Corporate Vice President - Worldwide Operations |
Giovani Twigge |
49 | 2010 | Corporate Vice President - Worldwide Human Resources |
Conan Deady |
51 | 2013 | Corporate Vice President, Secretary |
George Fennell |
44 | 2011 | Corporate Vice President - Companion Animal Group |
Ali Naqui |
59 | 2012 | Corporate Vice President - Asia Pacific and Latin America Operations and Water Line of Business |
James Polewaczyk |
49 | 2012 | Corporate Vice President - CAG Reference Laboratories and Telemedicine Line of Business |
William End |
65 | Lead Independent Director | |
Thomas Craig |
58 | 1999 | Independent Director |
Rebecca Henderson |
52 | 2003 | Independent Director |
Barry Johnson |
69 | 2006 | Independent Director |
Brian McKeon |
50 | 2003 | Independent Director |
Robert Murray |
72 | 2005 | Independent Director |
M. Anne Szostak |
62 | 2012 | Independent Director |

